AnaptysBio
ANAB
116 hedge funds and large institutions have $2.39B invested in AnaptysBio in 2017 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 41 increasing their positions, 19 reducing their positions, and 7 closing their positions.
643% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 7
286% more capital invested
Capital invested by funds: $620M → $2.39B (+$1.77B)
116% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 19
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
63% more funds holding
Funds holding: 71 → 116 (+45)
44% more call options, than puts
Call options by funds: $20.4M | Put options by funds: $14.2M
14% more ownership
Funds ownership: 87.17% → 101.17% (+14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$106M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$83.3M |
| 3 |
O
OppenheimerFunds
New York
|
+$78M |
| 4 |
BlackRock
New York
|
+$52.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$38.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$57.8M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$41.6M |
| 3 |
PA
Perceptive Advisors
New York
|
-$16.6M |
| 4 |
Millennium Management
New York
|
-$10.8M |
| 5 |
JP Morgan Chase
New York
|
-$8.29M |
ANAB Hedge Fund Activity: Q4 2017 in Review
116 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q4 2017, worth a combined $2.39B — up 286% from $620M a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new ANAB positions and 7 closed out — a net gain of 45 holders — while 41 added to existing stakes and 19 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $106M. The largest seller was BVF Inc, cutting an estimated $57.8M.
- 116 institutional investors held AnaptysBio (ANAB) as of Q4 2017, up from 71 in Q3 2017.
- Funds reported $2.39B of AnaptysBio stock for Q4 2017, up 286% quarter-over-quarter.
- 52 funds opened new AnaptysBio positions in Q4 2017 and 7 closed out, a net change of +45 holders.
- The largest AnaptysBio buyer in Q4 2017 was Janus Henderson Group, an estimated $106M added.
- The largest AnaptysBio seller in Q4 2017 was BVF Inc, an estimated $57.8M sold.
Based on aggregated 13F filings for Q4 2017.